Search Results
CYT387 50mg | 98.7%
APEXBIO TECHNOLOGY LLC
CYT387 10mg | 98.7%
APEXBIO TECHNOLOGY LLC
Baricitinib (LY3009104, INCB028050) 50mg | 98.06%
APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier PageBaricitinib (LY3009104, INCB028050) 200mg | 98.06%
APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier PageCYT387 10mM (in 1mL DMSO) | 98.7%
APEXBIO TECHNOLOGY LLC
CYT387 Evaluation Sample | 98.7%
APEXBIO TECHNOLOGY LLC
CYT387 5mg | 98.7%
APEXBIO TECHNOLOGY LLC
Baricitinib (LY3009104, INCB028050) 10mg | 98.06%
APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier PageBaricitinib (LY3009104, INCB028050) 5mg | 98.06%
APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier Page